Organon & Co.

NYSE:OGN 株式レポート

時価総額:US$4.1b

Organon 過去の業績

過去 基準チェック /46

Organonの収益は年間平均-29.7%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間2.1% 2.4%割合で 減少しています。 Organonの自己資本利益率は263.9%であり、純利益率は20.3%です。

主要情報

-29.7%

収益成長率

-30.0%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率-2.4%
株主資本利益率263.9%
ネット・マージン20.3%
前回の決算情報30 Sep 2024

最近の業績更新

Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

May 10
Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

Recent updates

The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 04
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis

Sep 19

These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Sep 13
These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Organon & Co.: Cheap With Caveats

Aug 22

Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Aug 09
Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Aug 07
Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum

Jul 30

Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

May 29
Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

May 10
Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

Four Reasons Why Organon Stock Is A Good Buy

May 07

Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Apr 21
Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Organon Stock Is Still Worth A Look

Feb 24

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Feb 19
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last

Feb 16

Organon: What I'm Looking For In This 8% Yield In 2024

Jan 03

High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued

Dec 19

Organon: It's Darkest Before The Dawn

Nov 30

Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace

Nov 07

Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Nov 05
Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Organon: The Federal Reserve Black Swan (Rating Upgrade)

Oct 04

6% Yield And Significantly Undervalued: A Closer Look At Organon

Sep 10

Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk

Aug 10

Organon & Co.: A Tough Spot To Be In Right Now

Jul 16

Organon goes ex-dividend tomorrow

Feb 23

Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 19
Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Is There Anything Organic Or Interesting About Organon?

Feb 07

Organon goes ex-dividend tomorrow

Nov 09

Organon's (NYSE:OGN) Dividend Will Be $0.28

Nov 08
Organon's (NYSE:OGN) Dividend Will Be $0.28

Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Nov 05
Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

収支内訳

Organon の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:OGN 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 246,4091,3011,757473
30 Jun 246,3461,0001,873499
31 Mar 246,3471,0471,887511
31 Dec 236,2631,0231,891528
30 Sep 236,1505851,892536
30 Jun 236,1687541,794526
31 Mar 236,1457461,766504
31 Dec 226,1749171,702471
30 Sep 226,2921,0111,717439
30 Jun 226,3551,1071,665398
31 Mar 226,3651,3041,658368
31 Dec 216,3041,3511,669339
30 Sep 216,3141,5251,620289
30 Jun 216,3271,7621,553257
31 Mar 216,2581,9171,421232
31 Dec 206,5322,2561,356210
31 Dec 197,7773,3061,443220
31 Dec 189,7772,1531,956365
31 Dec 1710,5001,8012,250355

質の高い収益: OGNは 高品質の収益 を持っています。

利益率の向上: OGNの現在の純利益率 (20.3%)は、昨年(9.5%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: OGNの収益は過去 5 年間で年間29.7%減少しました。

成長の加速: OGNの過去 1 年間の収益成長率 ( 122.4% ) は、5 年間の平均 ( 年間-29.7%を上回っています。

収益対業界: OGNの過去 1 年間の収益成長率 ( 122.4% ) はPharmaceuticals業界54.6%を上回りました。


株主資本利益率

高いROE: OGNの 自己資本利益率 ( 263.89% ) は 抜群 ですが、負債レベルが高いためこの指標は歪んでいます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘